CORVUS PHARMACEUTICALS INC

Ticker: CRVS CUSIP: 221015100 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 216,248 Value ($000) $1,665 Avg Close $7.89 Range $6.39 - $9.60

Q2 2025

Shares 201,651 Value ($000) $807 Avg Close $3.64 Range $2.54 - $4.62

Q1 2025

Shares 154,771 Value ($000) $492 Avg Close $4.71 Range $3.08 - $6.47

Q3 2024

Shares 323,211 Value ($000) $1,707 Avg Close $3.59 Range $1.75 - $6.15

Q2 2024

Shares 74,559 Value ($000) $136 Avg Close $1.86 Range $1.30 - $2.35

Q3 2023

Shares 198,220 Value ($000) $289 Avg Close $2.11 Range $1.37 - $3.16

Q2 2023

Shares 299,140 Value ($000) $685 Avg Close $2.08 Range $0.72 - $4.19

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	216,248	$1,665	$7.89	$6.39 - $9.60
Q2 2025	201,651	$807	$3.64	$2.54 - $4.62
Q1 2025	154,771	$492	$4.71	$3.08 - $6.47
Q3 2024	323,211	$1,707	$3.59	$1.75 - $6.15
Q2 2024	74,559	$136	$1.86	$1.30 - $2.35
Q3 2023	198,220	$289	$2.11	$1.37 - $3.16
Q2 2023	299,140	$685	$2.08	$0.72 - $4.19